Skip to results
Modify your search
NARROW
1-20 of 21
Authors: Jan C. Buckner
Journal Article
EDITOR'S CHOICE
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma
Neuro-Oncology, Volume 22, Issue 6, June 2020, Pages 830–837, https://doi.org/10.1093/neuonc/noaa021
Published: 30 January 2020
Journal Article
NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi138, https://doi.org/10.1093/neuonc/nox168.567
Published: 06 November 2017
Journal Article
ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi8, https://doi.org/10.1093/neuonc/nox168.028
Published: 06 November 2017
Journal Article
QLIF-08. DETERMINING THE NET CLINICAL BENEFIT IN NEURO-ONCOLOGY CLINICAL TRIALS BY COMBINING SURVIVAL AND TOXICITY DATA
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi202, https://doi.org/10.1093/neuonc/nox168.818
Published: 06 November 2017
Journal Article
Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Neuro-Oncology, Volume 20, Issue 2, February 2018, Pages 184–191, https://doi.org/10.1093/neuonc/nox175
Published: 07 September 2017
Journal Article
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Neuro-Oncology, Volume 20, Issue 4, April 2018, Pages 546–556, https://doi.org/10.1093/neuonc/nox161
Published: 22 August 2017
Journal Article
Adjuvant nitrosoureas: will they ever go away?
Neuro-Oncology, Volume 19, Issue 2, 1 February 2017, Pages 145–146, https://doi.org/10.1093/neuonc/now268
Published: 20 February 2017
Journal Article
MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi106, https://doi.org/10.1093/neuonc/now212.444
Published: 07 November 2016
Journal Article
Success, significance, and social responsibility Get access
Neuro-Oncology, Volume 17, Issue 5, May 2015, Pages 629–630, https://doi.org/10.1093/neuonc/nov030
Published: 16 March 2015
Journal Article
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K Get access
Neuro-Oncology, Volume 17, Issue 9, September 2015, Pages 1261–1269, https://doi.org/10.1093/neuonc/nou328
Published: 18 December 2014
Journal Article
Impact of imaging measurements on response assessment in glioblastoma clinical trials Get access
Neuro-Oncology, Volume 16, Issue suppl_7, October 2014, Pages vii24–vii35, https://doi.org/10.1093/neuonc/nou286
Published: 01 October 2014
Journal Article
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials Get access
Neuro-Oncology, Volume 15, Issue 11, November 2013, Pages 1568–1579, https://doi.org/10.1093/neuonc/not117
Published: 18 September 2013
Journal Article
Changes in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty years Get access
Neuro-Oncology, Volume 15, Issue 8, August 2013, Pages 1102–1110, https://doi.org/10.1093/neuonc/not080
Published: 27 June 2013
Journal Article
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma Get access
Neuro-Oncology, Volume 13, Issue 5, May 2011, Pages 530–535, https://doi.org/10.1093/neuonc/nor044
Published: 01 January 2011
Journal Article
Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma Get access
Neuro-Oncology, Volume 12, Issue 2, February 2010, Pages 164–172, https://doi.org/10.1093/neuonc/nop019
Published: 22 December 2009
Journal Article
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme Get access
Neuro-Oncology, Volume 9, Issue 1, January 2007, Pages 29–38, https://doi.org/10.1215/15228517-2006-025
Published: 01 January 2007
Journal Article
Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods Get access
Neuro-Oncology, Volume 8, Issue 2, April 2006, Pages 156–165, https://doi.org/10.1215/15228517-2005-005
Published: 01 April 2006
Journal Article
GNOSIS: Guidelines for neuro-oncology: Standards for investigational studies—reporting of phase 1 and phase 2 clinical trials Get access
Neuro-Oncology, Volume 7, Issue 4, October 2005, Pages 425–434, https://doi.org/10.1215/S1152851705000554
Published: 01 October 2005
Journal Article
Unusual presentation of adult metastatic peritoneal medulloblastoma associated with a ventriculoperitoneal shunt: A case study and review of the literature Get access
Neuro-Oncology, Volume 5, Issue 3, July 2003, Pages 217–220, https://doi.org/10.1215/S115285170200042X
Published: 01 July 2003
Journal Article
The neurocognitive effects of radiation in adult low-grade glioma patients Get access
Neuro-Oncology, Volume 5, Issue 3, July 2003, Pages 161–167, https://doi.org/10.1215/S1152851702000431
Published: 01 July 2003
